Journal
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
Volume 55, Issue 5, Pages 506-516Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/0004867421998763
Keywords
Suicide; suicidal ideation; depression; youth
Categories
Funding
- Australian National Health and Medical Research Council (NHMRC)
- NHMRC [1059660, 1156072, 1145634, APP1136344]
- Auckland Medical Research Foundation Douglas Goodfellow Repatriation Fellowship
- Emerging Leadership 1 Fellowship - NHMRC
- National Health and Medical Research Council of Australia [1145634, 1156072] Funding Source: NHMRC
Ask authors/readers for more resources
This study analyzed data from a multicenter trial on youth depression alleviation, identifying two distinct depression trajectories and four distinct suicidal ideation trajectories. Treatment allocation did not show significant associations with trajectory membership for depression or suicidal ideation. The findings highlight the importance of understanding the course of depression and suicidal ideation during treatment for managing suicide risk effectively.
Objectives: Effective treatment of depression is a key target for suicide prevention strategies. However, only around one-third of young people with suicide risk respond to evidence-based treatments. Understanding the trajectory of suicidal ideation, as a marker of suicide risk, over the course of evidence-based treatment for depression might provide insight into more targeted and effective treatments. Methods: This is a secondary analysis of data from the multicentre Youth Depression Alleviation-Combined Treatment trial. A total of 153 young people aged 15-25 years diagnosed with major depressive disorder were randomly assigned in this double-blind, placebo-controlled trial to either cognitive behavioural therapy plus fluoxetine or cognitive behavioural therapy plus placebo. Participants were assessed for depression and suicidal ideation at baseline and at weeks 4, 8 and 12. Results: Using group-based trajectory modelling, we identified two distinct depression trajectories. The first (Improving; 54.9%; n = 83) comprised those who experienced a consistent decline in depression symptoms. The second (Persisting; 45.1%; n = 70) comprised those who, despite treatment, still had clinically significant levels of depression by the end of treatment. For suicidal ideation, we identified four distinct trajectories: Non-clinical (15.5%; n = 20), Low Improving (47.1%; n = 75), High Improving (24.8%; n = 38) and High Persisting (12.7%; n = 20). Treatment allocation was not significantly associated with trajectory membership for either depression or suicidal ideation. Conclusion: Understanding the course of depression and suicidal ideation during treatment has important implications for managing suicide risk. The findings suggest that there is an identifiable group of young people for whom enhanced psychological and/or pharmacological intervention might be required to ensure a better treatment response. Specific interventions for those with suicidal ideation may also be prudent from the outset.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available